1. Home
  2. BAK vs COLL Comparison

BAK vs COLL Comparison

Compare BAK & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braskem SA ADR

BAK

Braskem SA ADR

HOLD

Current Price

$3.75

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$33.45

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAK
COLL
Founded
1972
2002
Country
Brazil
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
BAK
COLL
Price
$3.75
$33.45
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$4.40
$51.40
AVG Volume (30 Days)
3.3M
557.1K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.73
Revenue
N/A
$780,567,000.00
Revenue This Year
$16.02
$8.01
Revenue Next Year
$7.04
N/A
P/E Ratio
N/A
$20.19
Revenue Growth
N/A
23.62
52 Week Low
$2.32
$25.87
52 Week High
$5.30
$50.79

Technical Indicators

Market Signals
Indicator
BAK
COLL
Relative Strength Index (RSI) 46.54 38.00
Support Level $3.36 $31.18
Resistance Level $3.97 $36.20
Average True Range (ATR) 0.28 1.26
MACD 0.01 0.49
Stochastic Oscillator 39.52 33.83

Price Performance

Historical Comparison
BAK
COLL

About BAK Braskem SA ADR

Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: